Asset Management One Co. Ltd. boosted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 4.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 392,938 shares of the company's stock after purchasing an additional 16,036 shares during the quarter. Asset Management One Co. Ltd.'s holdings in Colgate-Palmolive were worth $36,076,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of CL. Chicago Partners Investment Group LLC boosted its stake in shares of Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company's stock valued at $591,000 after acquiring an additional 943 shares during the last quarter. Peak Financial Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $1,315,000. Gordian Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the third quarter valued at $602,000. Carrera Capital Advisors boosted its stake in shares of Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company's stock valued at $4,066,000 after acquiring an additional 7,353 shares during the last quarter. Finally, Fiduciary Alliance LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $4,066,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive Stock Performance
Colgate-Palmolive stock traded up $0.62 during mid-day trading on Tuesday, hitting $86.66. 1,296,742 shares of the company's stock traded hands, compared to its average volume of 4,875,798. The firm has a 50 day moving average price of $89.39 and a 200 day moving average price of $96.22. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The company has a market cap of $70.80 billion, a PE ratio of 24.59, a price-to-earnings-growth ratio of 4.12 and a beta of 0.44. Colgate-Palmolive has a one year low of $83.70 and a one year high of $109.30.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the firm posted $0.87 EPS. On average, equities analysts forecast that Colgate-Palmolive will post 3.73 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.31%. Colgate-Palmolive's dividend payout ratio is 56.82%.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on the company. StockNews.com lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Wells Fargo & Company decreased their price target on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research note on Tuesday, January 7th. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research note on Wednesday, January 8th. Raymond James reissued an "outperform" rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Finally, UBS Group decreased their price target on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $101.16.
Read Our Latest Stock Analysis on Colgate-Palmolive
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
